StockDrifts LogoStockDrifts

Madison Avenue Partners 13F Portfolio

Portfolio Manager
Madison Avenue Partners LP
Performance
+58.09% (2026 Q2)
AUM (13F)
$2.32B
# of Holdings
25
Performance Rank
Allocation (Top 20)
95.61%
Latest filing
Q2 2026

Madison Avenue Partners LP Holdings Map

Top 24 Madison Avenue Partners LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
GHC
GRAHAM HLDGS CO
12.11%246.4K$281.2M
+0.22%(+539)
2025-Q2: 245.3K shares2025-Q3: 245.8K shares2025-Q4: 245.8K shares2026-Q1: 245.8K shares2026-Q2: 246.4K shares
$560.69(+109.43%)
2026-06-30
INVH
INVITATION HOMES INC
10.84%8.34M$251.8Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 8.34M shares
$27.49(+10.22%)
2026-06-30
MKL
MARKEL GROUP INC
9.44%112.3K$219.4M
+27.80%(+24.44K)
2025-Q2: 84.3K shares2025-Q3: 84.3K shares2025-Q4: 87.9K shares2026-Q1: 87.9K shares2026-Q2: 112.3K shares
$1831.83(+0.28%)
2026-06-30
CPNG
COUPANG INC
9.31%12.46M$216.4M
+33.04%(+3.09M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 9.36M shares2026-Q2: 12.46M shares
$20.39(-20.09%)
2026-06-30
MICC
MAGNUM ICE CREAM CO NV
8.16%10.89M$189.6M
-4.83%(-552.94K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 6.43M shares2026-Q1: 11.45M shares2026-Q2: 10.89M shares
$15.65(+27.20%)
2026-06-30
TBPH
THERAVANCE BIOPHARMA INC
6.74%9.21M$156.6M
-3.14%(-298.90K)
2025-Q2: 9.51M shares2025-Q3: 9.51M shares2025-Q4: 9.51M shares2026-Q1: 9.51M shares2026-Q2: 9.21M shares
$9.98(+69.52%)
2026-06-30
SOLV
SOLVENTUM CORP
5.78%1.74M$134.3M
-7.17%(-134.51K)
2025-Q2: 2.24M shares2025-Q3: 1.99M shares2025-Q4: 1.99M shares2026-Q1: 1.88M shares2026-Q2: 1.74M shares
$61.23(+41.21%)
2026-06-30
STAA
STAAR SURGICAL CO
5.16%4.18M$119.8M
+71.02%(+1.73M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 2.44M shares2026-Q2: 4.18M shares
$21.98(+12.47%)
2026-06-30
INDV
INDIVIOR PLC
5.08%2.87M$117.9M
-33.39%(-1.44M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 6.28M shares2026-Q1: 4.32M shares2026-Q2: 2.87M shares
$12.07(+216.57%)
2026-06-30
GLPG
LAKEFRONT BIOTHERAPEUTICS NV
4.45%3.45M$103.4M
+39.86%(+982.63K)
2025-Q2: 1.88M shares2025-Q3: 2.20M shares2025-Q4: 2.21M shares2026-Q1: 2.47M shares2026-Q2: 3.45M shares
$28.29(-1.26%)
2026-06-30

About Madison Avenue Partners LPโ€™s portfolio

Madison Avenue Partners LP reports $2.32B in US-listed equity holdings across 25 positions in its most recent 13F filing. Its largest disclosed positions are GHC (12.1%), INVH (10.8%) and MKL (9.4%). The top 20 holdings account for 95.61% of reported assets. Its disclosed equity book has returned +377.18% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
GHC โ€” 12.5% ($281.21M)INVH โ€” 11.2% ($251.81M)MKL โ€” 9.7% ($219.37M)CPNG โ€” 9.6% ($216.38M)MICC โ€” 8.4% ($189.64M)TBPH โ€” 6.9% ($156.61M)SOLV โ€” 6.0% ($134.34M)STAA โ€” 5.3% ($119.80M)INDV โ€” 5.2% ($117.94M)GLPG โ€” 4.6% ($103.37M)Other โ€” 20.6% ($463.71M)
79%in top 10
  • GHC12.5%
  • INVH11.2%
  • MKL9.7%
  • CPNG9.6%
  • MICC8.4%
  • TBPH6.9%
  • SOLV6.0%
  • STAA5.3%
  • INDV5.2%
  • GLPG4.6%
  • Other20.6%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
6
INVHINVITATION HOMES INC10.8%
SANMSANMINA CORP2.0%
PRIMPRIMORIS SVCS CORP2.0%
ADARRAY DIGITAL INFRASTRUCTURE1.7%
+2 opened
Added to
7
CPNGCOUPANG INC+33.0%
STAASTAAR SURGICAL CO+71.0%
MKLMARKEL GROUP INC+27.8%
GLPGLAKEFRONT BIOTHERAPEUTICS NV+39.9%
+3 more
Trimmed
8
SNDKSANDISK CORP-98.4%
INDVINDIVIOR PLC-33.4%
SOLVSOLVENTUM CORP-7.2%
MICCMAGNUM ICE CREAM CO NV-4.8%
+4 more

Unlock alerts, watchlists & AI chat

Sign up free to track Madison Avenue Partners LP, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Madison Avenue Partners LPโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1801265). View Madison Avenue Partners LPโ€™s 13F filings on SEC

More 13F analyses

View all